Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. 2009

Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
Association of Dutch Burn Centres Beverwijk, the Netherlands.

Normotrophic, hypertrophic, and keloidal scars are different types of scar formation, which all need a different approach in treatment. Therefore, it is important to differentiate between these types of scar, not only clinically but also histopathologically. Differences were explored for collagen orientation and bundle thickness in 25 normal skin, 57 normotrophic scar, 56 hypertrophic scar, and 56 keloid biopsies, which were selected on clinical diagnosis. Image analysis was performed by fast fourier transformation. The calculated collagen orientation index ranged from 0 (random orientation) to 1 (parallel orientation). The bundle distance was calculated by the average distance between the centers of the collagen bundles. The results showed that compared with all three types of scars, the collagen orientation index was significantly lower in normal skin, which indicates that scars are organized in a more parallel manner. No differences were found between the different scars. Secondly, compared with normal skin, normotrophic scar, and hypertrophic scar, the bundle distance was significantly larger in keloidal scar, which suggests that thicker collagen bundles are present in keloidal scar. This first extensive histological study showed objective differences between normal skin, normotrophic, hypertrophic, and keloidal scar.

UI MeSH Term Description Entries
D007627 Keloid A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues. Keloids
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002921 Cicatrix The fibrous tissue that replaces normal tissue during the process of WOUND HEALING. Scars,Cicatrization,Scar,Scarring
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
February 1975, European journal of clinical investigation,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
April 2018, Tissue engineering. Part C, Methods,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
June 2010, The British journal of dermatology,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
July 1994, The American journal of pathology,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
October 2004, The American Journal of dermatopathology,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
January 1971, Surgical forum,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
January 1972, Surgical forum,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
December 1973, The British journal of dermatology,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
February 1979, Journal of cellular physiology,
Pauline D H M Verhaegen, and Paul P M van Zuijlen, and Noor M Pennings, and Jan van Marle, and Frank B Niessen, and Chantal M A M van der Horst, and Esther Middelkoop
August 1991, Plastic and reconstructive surgery,
Copied contents to your clipboard!